CROI 2024 Program Guide

Interactive Symposia

Introductions (Part 1)

132 4:05 PM

COVID-19 Incidence and Severity in Persons With Reinfection vs Post-Vaccination Breakthrough Infection Adeel A. Butt , Peng Yan, Obaid S Shaikh mRNA Vaccine Versus Hybrid Immunity Against COVID-19 Among People With HIV During Omicron Wave Asa Tapley , Aaron Hudson, Bo Zhang, Jessica Andriesen, Leigh H Fisher, Craig A Magaret, Margaret Yacovone, Peter B Gilbert, Corey Larry, Glenda Gray, Sufia Dadabhai, Philip Kotze, Yunda Huang, Nigel Garrett, for the CoVPN 3008 Ubuntu Study Team SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency Yijia Li , Manish C Choudhary, James Regan, Julie Boucau, Anusha Nathan, Tessa Speidel, May Y Liew, Gregory E Edelstein, Michael S Seaman, Gaurav D Gaiha, Mark J Siedner, Amy K Barczak, Jacob E Lemieux, Jonathan Z Li, for the POSITIVES Study Team Analysis of Emergent SARS-CoV-2 Antiviral Resistance and Its Association With Virologic Rebound Trevor J. Tamura , Fizah Yousuf, Manish C Choudhary, Rinki Deo, Anadela Navarrete Gomez, Gregory E Edelstein, Julie Boucau, Dessie Tien, Tammy D Vyas, Robert W Shafer, Mark J Siedner, Amy K Barczak, Jacob E Lemieux, Jonathan Z Li, for the POSITIVES Study Team Molnupiravir Does Not Increase 3CLpro Resistance Mutations When Co-Administered With Nirmatrelvir/r Shuntai Zhou , Nathan Long, Kyle Rosenke, Michael A Jarvis, Heinz Feldmann, Ronald Swanstrom Mini-Lecture: Progress in Understanding the Mechanisms of Long COVID Annukka A. R. Antar Multimodal Assessment of Antigen Persistence in the Post Acute Phase of SARS-CoV-2 Infection Michael J. Peluso , Sarah Goldberg, Zoe Swank, Brian H Lafranchi, Scott Lu, Thomas Dalhuisen, Badri Viswanathan, Ma Somsouk, J D Kelly, Steven G Deeks, Zoltan Laszik, David Walt, Jeffrey Martin, Timothy J Henrich, for the LIINC Study Team

133 4:13 PM

134 4:21 PM

135 4:29 PM NIS

Monday

Questions and Answers (Part 1) Introductions (Part 2)

136 5:00 PM

137 5:08 PM

138 5:18 PM

Questions and Answers (Part 2)

CROI 2024 39

New Investigator Scholarship

LB

NIS

Late-Breaking